Direct Oral Anticoagulants in Patients with Liver Disease in the Era of Non-Alcoholic Fatty Liver Disease Global Epidemic: A Narrative Review
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Direct Oral Anticoagulants in Patients with Liver Disease in the Era of Non-Alcoholic Fatty Liver Disease Global Epidemic: A Narrative Review
Authors
Keywords
-
Journal
ADVANCES IN THERAPY
Volume 37, Issue 5, Pages 1910-1932
Publisher
Springer Science and Business Media LLC
Online
2020-04-14
DOI
10.1007/s12325-020-01307-z
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Nonalcoholic Fatty Liver Disease Pandemic Fuels the Upsurge in Cardiovascular Diseases
- (2020) Jingjing Cai et al. CIRCULATION RESEARCH
- Direct oral anticoagulants and warfarin in patients with cirrhosis: a comparison of outcomes
- (2020) Kyle A. Davis et al. JOURNAL OF THROMBOSIS AND THROMBOLYSIS
- Impact of Liver Disease on Oral Anticoagulant Prescription and Major Adverse Events in Patients with Atrial Fibrillation
- (2020) Marco Proietti et al. European Heart Journal-Cardiovascular Pharmacotherapy
- Association between non-alcoholic fatty liver disease and risk of atrial fibrillation in adult individuals: an updated meta-analysis
- (2019) Alessandro Mantovani et al. LIVER INTERNATIONAL
- Direct Oral Anticoagulants in Cirrhotic Patients: Current Evidence and Clinical Observations
- (2019) Sherif Elhosseiny et al. Canadian Journal of Gastroenterology and Hepatology
- Anticoagulation for Atrial Fibrillation in Cirrhosis of the Liver: Are Low‐Dose Non‐Vitamin K Oral Anticoagulants a Reasonable Alternative to Warfarin?
- (2019) Celine Gallagher et al. Journal of the American Heart Association
- Anticoagulation in Cirrhosis and Portal Vein Thrombosis Is Safe and Improves Prognosis in Advanced Cirrhosis
- (2019) Carlos Noronha Ferreira et al. DIGESTIVE DISEASES AND SCIENCES
- Reversal of Direct Oral Anticoagulants: Guidance from the Anticoagulation Forum
- (2019) Adam Cuker et al. AMERICAN JOURNAL OF HEMATOLOGY
- Direct Oral Anticoagulants in Chronic Liver Disease
- (2019) Taylor D. Steuber et al. ANNALS OF PHARMACOTHERAPY
- Prevalence of atrial fibrillation in the Italian elderly population and projections from 2020 to 2060 for Italy and the European Union: the FAI Project
- (2019) Antonio Di Carlo et al. EUROPACE
- Coagulation in Cirrhosis
- (2019) Jacqueline G. O’Leary et al. GASTROENTEROLOGY
- Safety of Direct Oral Anticoagulants in Patients with Cirrhosis: A Systematic Review and Meta-analysis
- (2019) Kamolyut Lapumnuaypol et al. QJM-AN INTERNATIONAL JOURNAL OF MEDICINE
- Efficacy and safety of direct oral anticoagulant therapy for the treatment of venous thromboembolism in patients with chronic liver disease
- (2019) Kyle A. Davis et al. THROMBOSIS RESEARCH
- Thromboelastography‐Guided Blood Component Use in Patients With Cirrhosis With Nonvariceal Bleeding: A Randomized Controlled Trial
- (2019) Manoj Kumar et al. HEPATOLOGY
- Direct Oral Anticoagulants in Patients With Atrial Fibrillation and Liver Disease
- (2019) So-Ryoung Lee et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Oral Anticoagulants in Liver Disease
- (2019) Elaine M. Hylek et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- 2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS)
- (2019) Stavros V Konstantinides et al. EUROPEAN HEART JOURNAL
- Extra-hepatic manifestations and complications of nonalcoholic fatty liver disease
- (2019) Stefano Ballestri et al. Future Medicinal Chemistry
- Portal vein thrombosis in cirrhosis: Why a well-known complication is still matter of debate
- (2019) Mariella Faccia et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Cardiovascular Risk in Non-Alcoholic Fatty Liver Disease: Mechanisms and Therapeutic Implications
- (2019) Claudio Tana et al. International Journal of Environmental Research and Public Health
- Transfusion strategies in patients with cirrhosis
- (2019) Patricia Liu et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- NASH Leading Cause of Liver Transplant in Women: Updated Analysis of Indications For Liver Transplant and Ethnic and Gender Variances
- (2018) Mazen Noureddin et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Thrombin and factor Xa link the coagulation system with liver fibrosis
- (2018) Ameet Dhar et al. BMC GASTROENTEROLOGY
- Nonalcoholic Fatty Liver Disease and Risk of Incident Type 2 Diabetes: A Meta-analysis
- (2018) Alessandro Mantovani et al. DIABETES CARE
- The 2018 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation
- (2018) Jan Steffel et al. EUROPEAN HEART JOURNAL
- Rivaroxaban-induced hepatotoxicity
- (2018) Anna Licata et al. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
- Safety of direct oral anticoagulants vs warfarin in patients with chronic liver disease and atrial fibrillation
- (2018) Pavel Goriacko et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Drug plasma level measurement in management of severe bleeding during direct oral anticoagulant treatment: case report and perspective
- (2018) Dimitriy Arioli et al. Internal and Emergency Medicine
- Incidence of bleeding in patients with atrial fibrillation and advanced liver fibrosis on treatment with vitamin K or non-vitamin K antagonist oral anticoagulants
- (2018) Daniele Pastori et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Hypertension, diabetes, atherosclerosis and NASH: Cause or consequence?
- (2018) Amedeo Lonardo et al. JOURNAL OF HEPATOLOGY
- EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis
- (2018) Paolo Angeli et al. JOURNAL OF HEPATOLOGY
- Oral Anticoagulation in Patients With Liver Disease
- (2018) Arman Qamar et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Non–Vitamin K Antagonist Oral Anticoagulants and Risk of Serious Liver Injury
- (2018) Antonios Douros et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Risk of cardiomyopathy and cardiac arrhythmias in patients with nonalcoholic fatty liver disease
- (2018) Quentin M. Anstee et al. Nature Reviews Gastroenterology & Hepatology
- Randomized controlled trial of rivaroxaban versus warfarin in the management of acute non-neoplastic portal vein thrombosis
- (2018) Amr Shaaban Hanafy et al. VASCULAR PHARMACOLOGY
- Risks and benefits of direct oral anticoagulants versus warfarin in a real world setting: cohort study in primary care
- (2018) Yana Vinogradova et al. BMJ-British Medical Journal
- Risks and benefits of direct oral anticoagulants versus warfarin in a real world setting: cohort study in primary care
- (2018) Yana Vinogradova et al. BMJ-British Medical Journal
- Increased risk of venous thromboembolism in hospitalized patients with cirrhosis due to non-alcoholic steatohepatitis
- (2018) Jonathan G. Stine et al. Clinical and Translational Gastroenterology
- Direct oral anticoagulants in patients with liver cirrhosis: A systematic review
- (2018) Evert Willian Hoolwerf et al. THROMBOSIS RESEARCH
- Coagulation, Microenvironment and Liver Fibrosis
- (2018) Niccolò Bitto et al. Cells
- A round trip from nonalcoholic fatty liver disease to diabetes: molecular targets to the rescue?
- (2018) Amedeo Lonardo et al. ACTA DIABETOLOGICA
- Efficacy and safety of anticoagulation for atrial fibrillation in patients with cirrhosis: A systematic review and meta-analysis
- (2018) Ronpichai Chokesuwattanaskul et al. DIGESTIVE AND LIVER DISEASE
- The efficacy and safety of direct oral anticoagulants vs traditional anticoagulants in cirrhosis
- (2017) Justine Hum et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Gastrointestinal Bleeding and Direct Oral Anticoagulants Amongst Patients With Atrial Fibrillation in the “Real World”
- (2017) Michał Mazurek et al. GASTROENTEROLOGY
- Gastrointestinal Safety of Direct Oral Anticoagulants: A Large Population-Based Study
- (2017) Neena S. Abraham et al. GASTROENTEROLOGY
- Effects of Anticoagulants in Patients With Cirrhosis and Portal Vein Thrombosis: A Systematic Review and Meta-analysis
- (2017) Lorenzo Loffredo et al. GASTROENTEROLOGY
- Prospective study of oral anticoagulants and risk of liver injury in patients with atrial fibrillation
- (2017) Alvaro Alonso et al. HEART
- Efficacy and safety of edoxaban for treatment of portal vein thrombosis following danaparoid sodium in patients with liver cirrhosis
- (2017) Yuko Nagaoki et al. HEPATOLOGY RESEARCH
- Risks Versus Benefits of Anticoagulation for Atrial Fibrillation in Cirrhotic Patients
- (2017) Jonggi Choi et al. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
- Procoagulant imbalance in patients with non-alcoholic fatty liver disease
- (2017) Armando Tripodi et al. JOURNAL OF HEPATOLOGY
- Anticoagulation in chronic liver disease
- (2017) Ameet Dhar et al. JOURNAL OF HEPATOLOGY
- 2017 ACC Expert Consensus Decision Pathway on Management of Bleeding in Patients on Oral Anticoagulants
- (2017) Gordon F. Tomaselli et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- The risk of venous thromboembolism in patients with cirrhosis
- (2017) Pasquale Ambrosino et al. THROMBOSIS AND HAEMOSTASIS
- Gastrointestinal bleeding in patients on novel oral anticoagulants: Risk, prevention and management
- (2017) Ka-Shing Cheung et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Liver Cirrhosis in Patients With Atrial Fibrillation: Would Oral Anticoagulation Have a Net Clinical Benefit for Stroke Prevention?
- (2017) Ling Kuo et al. Journal of the American Heart Association
- Changing Concepts of Cirrhotic Coagulopathy
- (2016) Armando Tripodi et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Anticoagulation in Patients With Cirrhosis
- (2016) Nghi B. Ha et al. ANNALS OF PHARMACOTHERAPY
- Antithrombotic Therapy for VTE Disease
- (2016) Clive Kearon et al. CHEST
- Direct Oral Anticoagulants in Cirrhosis Patients Pose Similar Risks of Bleeding When Compared to Traditional Anticoagulation
- (2016) N. M. Intagliata et al. DIGESTIVE DISEASES AND SCIENCES
- 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS
- (2016) Paulus Kirchhof et al. EUROPEAN HEART JOURNAL
- Toward a Comprehensive New Classification of Portal Vein Thrombosis in Patients With Cirrhosis
- (2016) Shiv K. Sarin et al. GASTROENTEROLOGY
- Portal hypertensive bleeding in cirrhosis: Risk stratification, diagnosis, and management: 2016 practice guidance by the American Association for the study of liver diseases
- (2016) Guadalupe Garcia-Tsao et al. HEPATOLOGY
- Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes
- (2016) Zobair M. Younossi et al. HEPATOLOGY
- Nonalcoholic fatty liver disease is associated with an almost twofold increased risk of incident type 2 diabetes and metabolic syndrome. Evidence from a systematic review and meta-analysis
- (2016) Stefano Ballestri et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Non-alcoholic fatty liver disease and risk of incident cardiovascular disease: A meta-analysis
- (2016) Giovanni Targher et al. JOURNAL OF HEPATOLOGY
- Preserved hemostatic status in patients with non-alcoholic fatty liver disease
- (2016) Wilma Potze et al. JOURNAL OF HEPATOLOGY
- Antithrombotic treatment with direct-acting oral anticoagulants in patients with splanchnic vein thrombosis and cirrhosis
- (2016) Andrea De Gottardi et al. LIVER INTERNATIONAL
- Thrombelastography-guided blood product use before invasive procedures in cirrhosis with severe coagulopathy: A randomized, controlled trial
- (2015) Lesley De Pietri et al. HEPATOLOGY
- Direct oral anticoagulants in atrial fibrillation: can data from randomized clinical trials be safely transferred to the general population? No
- (2015) Marco Marietta Internal and Emergency Medicine
- An open-label, phase 1 study to evaluate the effects of hepatic impairment on edoxaban pharmacokinetics and pharmacodynamics
- (2015) Jeanne Mendell et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Prothrombotic genetic risk factors are associated with an increased risk of liver fibrosis in the general population
- (2015) Elisabeth P.C. Plompen et al. JOURNAL OF HEPATOLOGY
- Increased risk of portal vein thrombosis in patients with cirrhosis due to nonalcoholic steatohepatitis
- (2015) Jonathan G. Stine et al. LIVER TRANSPLANTATION
- Comparison of Anti-Xa and Activated Partial Thromboplastin Time Monitoring for Heparin Dosing in Patients With Cirrhosis
- (2015) Amaris Fuentes et al. THERAPEUTIC DRUG MONITORING
- Long-term Clinical Outcomes of Splanchnic Vein Thrombosis
- (2015) Walter Ageno et al. JAMA Internal Medicine
- Cirrhosis is Associated with an Increased 30-Day Mortality After Venous Thromboembolism
- (2015) Kirstine Kobberøe Søgaard et al. Clinical and Translational Gastroenterology
- Risk of drug-induced liver injury with the new oral anticoagulants: systematic review and meta-analysis
- (2014) Daniel Caldeira et al. HEART
- Procoagulant imbalance in patients with non-alcoholic fatty liver disease
- (2014) Armando Tripodi et al. JOURNAL OF HEPATOLOGY
- Risk-assessment and pharmacological prophylaxis of venous thromboembolism in hospitalized patients with chronic liver disease
- (2014) Hanin Bogari et al. THROMBOSIS RESEARCH
- Risk of cardiovascular, cardiac and arrhythmic complications in patients with non-alcoholic fatty liver disease
- (2014) Stefano Ballestri WORLD JOURNAL OF GASTROENTEROLOGY
- Epidemiology of atrial fibrillation: European perspective
- (2014) Massimo Zoni-Berisso et al. Clinical Epidemiology
- Effect of hepatic impairment on the pharmacokinetics and pharmacodynamics of a single dose of rivaroxaban, an oral, direct Factor Xa inhibitor
- (2013) Dagmar Kubitza et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Routine coagulation assays underestimate levels of antithrombin-dependent drugs but not of direct anticoagulant drugs in plasma from patients with cirrhosis
- (2013) Wilma Potze et al. BRITISH JOURNAL OF HAEMATOLOGY
- Prothrombotic factors in histologically proven nonalcoholic fatty liver disease and nonalcoholic steatohepatitis
- (2013) An Verrijken et al. HEPATOLOGY
- Established and new-generation antithrombotic drugs in patients with cirrhosis – Possibilities and caveats
- (2013) Ton Lisman et al. JOURNAL OF HEPATOLOGY
- Diagnosis and Management of Nonalcoholic Fatty Liver Disease and Its Hemostatic/Thrombotic and Vascular Complications
- (2013) Christopher Byrne et al. SEMINARS IN THROMBOSIS AND HEMOSTASIS
- Dismantling the myth of “autoanticoagulation” in cirrhosis: An old dogma dies hard
- (2012) Stephen Caldwell et al. HEPATOLOGY
- The Coagulopathy of Chronic Liver Disease
- (2011) Armando Tripodi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Increased coagulation factor VIII, IX, XI and XII activities in non-alcoholic fatty liver disease
- (2010) Anna Kotronen et al. LIVER INTERNATIONAL
- Low-molecular-weight heparin in patients with advanced cirrhosis
- (2010) Lars P. Bechmann et al. LIVER INTERNATIONAL
- High prevalence of nonalcoholic fatty liver in patients with idiopathic venous thromboembolism
- (2010) Matteo Nicola Dario Di Minno WORLD JOURNAL OF GASTROENTEROLOGY
- Coagulopathy Does Not Protect Against Venous Thromboembolism in Hospitalized Patients With Chronic Liver Disease
- (2009) Ousama Dabbagh et al. CHEST
- Parenchymal Extinction: Coagulation and Hepatic Fibrogenesis
- (2009) Quentin M. Anstee et al. Clinics in Liver Disease
- A most stubborn bias: no adjustment method fully resolves confounding by indication in observational studies
- (2009) Jaclyn L.F. Bosco et al. JOURNAL OF CLINICAL EPIDEMIOLOGY
- Definition of major bleeding in clinical investigations of antihemostatic medicinal products in surgical patients
- (2009) S. SCHULMAN et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Venous thromboembolism risk and prophylaxis in the acute hospital care setting (ENDORSE study): a multinational cross-sectional study
- (2008) Alexander T Cohen et al. LANCET
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now